Hematologic Malignancies Program
UMGCC Named Center of Excellence by Myelodysplastic Syndromes Foundation
Ask the Expert
Get answers to questions about Myelodysplastic Syndromes by e-mailing Dr. Maria Baer.
See Dr. Baer's Bio | Q&A Archive
Note: This is for informational purposes only. Doctors cannot provide a diagnosis via e-mail.
The University of Maryland Marlene and Stewart Greenebaum Cancer Center has been designated as a Center of Excellence by the Myelodysplastic Syndromes Foundation.
To be recognized as a Center of Excellence for treatment in myelodysplastic syndromes (MDS), a hospital must have:
- An established university (or equivalent) program
- Recognized morphologic expertise in MDS
- Available cytogenetics and/or molecular genetics
- Ongoing research, including Institutional Review Board-approved clinical trials
- Documentation of peer-reviewed publications in the field
- The ability and intention to register patients in the MDS International Registry Database
For More Information:
This page was last updated on: November 2, 2007.
|
Email this Page
Print this Page
